Chapter 9 (in part)

Metabolic Syndrome

By the start of the twenty-first century, a strange new epidemic was gaining ground across the developed world, with signs of its spread to emerging economies. Waistlines were expanding, blood pressure was rising, and adult-onset diabetes was no longer confined to adults. Clusters of symptoms—abdominal obesity, high triglycerides, low HDL, hypertension, and impaired glucose tolerance—were increasingly appearing together in the same individuals. The medical community named this cluster “metabolic syndrome.” But naming a condition is not the same as understanding its cause
.
Doctors were trained to look at individual components—obesity here, hypertension there, fatty liver as an incidental finding. But the syndrome was more than the sum of its parts.
Something was causing widespread metabolic dysregulation at the population level. That something was not just “too much food” or “not enough exercise.” It was not, as previously thought, dietary fat. The deeper culprit was sugar—and more specifically, fructose.

Fructose lies at the biochemical core of the metabolic syndrome. Through a cascade of mechanisms beginning in the liver, it drives the generation of uric acid, depletes cellular ATP, induces insulin resistance, stimulates de novo lipogenesis, promotes visceral adiposity, and fosters a chronic pro-inflammatory state. Unlike glucose, which can be metabolized by nearly every cell in the body, fructose is shunted primarily to the liver, where its metabolism is unregulated and rapid. This overload leads to hepatic fat accumulation and eventually systemic consequences.


9.1: Clinical Definition and Diagnosis

The term metabolic syndrome refers to a constellation of metabolic abnormalities that often occur together and significantly increase the risk of cardiovascular disease, type 2 diabetes, and nonalcoholic fatty liver disease. The most widely used clinical criteria come from the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III), which defines metabolic syndrome as the presence of three or more of the following five criteria:
Table 2.1: Diagnostic Criteria for Metabolic Syndrome (NCEP ATP III Definition)
Although these thresholds vary slightly among international guidelines, the clinical picture remains largely consistent across populations: central adiposity, insulin resistance, dyslipidemia, and elevated blood pressure.
Notably, liver enzymes (ALT, AST) are often mildly elevated in affected individuals, reflecting subclinical hepatic steatosis.
The syndrome itself may go unnoticed for years. Patients may present to their doctor with “a bit of belly fat,” or slightly elevated cholesterol. But under the surface, their metabolism is shifting toward catastrophe.


9.2: Fructose and the Biochemical Roots of Metabolic Syndrome

At the biochemical level, fructose initiates multiple pathological processes. Once absorbed from the intestine via GLUT5 and transported to the liver through GLUT2, fructose is rapidly phosphorylated by ketohexokinase (KHK) into fructose-1-phosphate.. This reaction bypasses the tightly regulated phosphofructokinase checkpoint of glycolysis, leading to a surge in unregulated substrate flow through the lower glycolytic pathway. The resulting intermediates are diverted toward de novo lipogenesis (DNL), generating triglycerides and fat droplets that accumulate in hepatocytes.

This hepatic lipid accumulation is a defining feature of metabolic syndrome and is strongly associated with elevated VLDL levels, reduced insulin sensitivity, and progression toward metabolic dysfunction-associated steatotic liver disease (MASLD). In parallel, the consumption of ATP during fructose metabolism increases AMP levels, activating AMP deaminase and generating uric acid, a compound long known to correlate with gout but now increasingly recognized as a metabolic toxin that impairs endothelial function and inhibits nitric oxide production, contributing to hypertension.

Meanwhile, fructose’s failure to stimulate insulin or leptin leads to persistent hunger, diminished satiety, and activation of central reward pathways. The net result is hyperphagia, visceral fat deposition, and further metabolic derailment.

Visceral adiposity is not merely excess body fat—it is a biologically active depot that secretes inflammatory cytokines, disrupts hormonal signaling, and impairs insulin action. Unlike subcutaneous fat, visceral fat accumulates in response to liver-derived triglycerides and directly contributes to insulin resistance.

Insulin resistance is not merely one feature of metabolic syndrome. It is at the core of the syndrome. It unifies the dyslipidemia, hypertension, the fatty liver, and the expanding waistline. He reacts to the syndrome radiates outward from this one source.

Fasting insulin levels begin to rise long before fasting glucose crosses the diagnostic threshold for pre-diabetes. The more fructose consumed, the higher the insulin burden required to maintain metabolic balance. In response to systemic insulin resistance, pancreatic β-cells increase insulin secretion in an effort to maintain euglycemia. This hyperinsulinemic state is not benign. Chronically elevated insulin levels not only drive further fat storage but also promote cellular growth signals that have been implicated in carcinogenesis. Over time, β-cell exhaustion can follow, leading to impaired glucose tolerance and type 2 diabetes mellitus.


9.3: Fructose and the Inflammatory Core of Metabolic Syndrome

While insulin resistance lies at the heart of metabolic syndrome, it does not act alone. Fructose consumption also triggers low-grade, chronic inflammation — a silent but powerful contributor to metabolic damage. As visceral fat accumulates and liver metabolism shifts, inflammatory signals rise, including C-reactive protein (CRP), a key biomarker of cardiovascular risk. This inflammatory state not only worsens insulin resistance but also sets the stage for the vascular complications explored in the chapters that follow.

This figure demonstrates the inflammatory consequences of excess fructose consumption. Figure: Fructose Intake and Inflammatory Marker Elevation. Green line: C-reactive protein (CRP) rises with increasing fructose, indicating systemic inflammation. Red line: TNF-α (tumor necrosis factor alpha), a pro-inflammatory cytokine, also rises in tandem.

These markers are linked to metabolic syndrome, atherosclerosis, and insulin resistance
As intake increases, levels of C-reactive protein (CRP) and tumor necrosis factor alpha (TNF-α) rise progressively. Both markers are predictive of cardiovascular events and are hallmarks of metabolic syndrome and insulin resistance. The data suggest that fructose is not metabolically silent—it is pro-inflammatory at a cellular and systemic level.

One of the most sensitive early indicators of metabolic dysfunction is the HOMA-IR score, short for Homeostatic Model Assessment of Insulin Resistance. It is a calculated value derived from a patient’s fasting glucose and fasting insulin levels, using the formula: HOMA-IR = (Fasting Insulin [μU/mL] × Fasting Glucose [mg/dL]) ÷ 405.

A HOMA-IR above 2.0 suggests emerging insulin resistance, while values above 3.0 are often seen in patients with full-blown metabolic syndrome. In many patients, this score begins to rise years before diabetes is diagnosed, serving as an early warning of metabolic overload — often from excessive fructose consumption. Although not yet routine in primary care, HOMA-IR offers a simple, inexpensive way to unmask the silent progression toward diabetes, fatty liver, and cardiovascular disease.


9.4: Childhood Obesity and the Early Onset of Metabolic Syndrome

One of the most alarming developments of the past two decades has been the appearance of metabolic syndrome in children and adolescents. Once considered a disease of middle age, fatty liver disease is now being diagnosed in eight-year-olds.

Rates of type 2 diabetes among teens have doubled in a single generation. In the United States, one in five children is obese, and many show early biochemical signs of insulin resistance and hepatic fat accumulation.

Notably the American Commonwealth of the Northern Marianas shares the reputation as having the most obese children and young adults in the world. (see map at bottom of this page)

Lest the food industry say this obesity epidemic is a matter of choice of calories in versus calories out and a sedentary lifestyle, the next map shows children age 5 to 14 with obesity.

The culprit is not hard to find. Children are not dining on foie gras or drinking red wine. They are drinking juice boxes, soda, and energy drinks. They are eating cereals loaded with sugar, and snacks designed for bliss-point addiction. Their diets are flooded with high fructose corn syrup (HFCS), a laboratory-created sweetener that delivers concentrated fructose to the liver in every sip and bite.

Childhood obesity cannot be blamed on personal choice.

The blame lies directly at the food industry who marketed fructose laden food at innocent parents to give to children as young as one year old, setting them on a path towards lifetime obesity and chronic illness.


9.5: Beyond Calories: The Role of Ultra-Processed Food

The metabolic syndrome cannot be understood through caloric balance alone. Studies controlling for calories and exercise have shown that isocaloric substitution of fructose for other carbohydrates leads to increased visceral fat, worsened lipid profiles, and greater insulin resistance. This effect is amplified when fructose is delivered in liquid form or consumed as part of an ultra-processed food matrix, where fiber and micronutrients are stripped away, and satiety signals are suppressed.

As explained in later chapters, these industrially designed foods were not an accident of modern agriculture. They were built for shelf life, marketability, and addictive potential. The metabolic consequences are not merely unfortunate side effects—they are the inevitable result of dietary engineering gone awry.

The Map below shows obesity in children world wide in 2021, with the Pacific Islands, (e.g. NorthernMarianas Islands) specifically mentioned because they now have the most obese and diabetic children in the world.